Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Pelvic organ prolapse in women: Diagnostic evaluation

Tola B Fashokun, MD, FACOG
Rebecca G Rogers, MD
Section Editor
Linda Brubaker, MD, FACOG
Deputy Editor
Kristen Eckler, MD, FACOG


Pelvic organ prolapse (POP), the herniation of the pelvic organs to or beyond the vaginal walls, occurs in up to 50 percent of parous women and causes a variety of pelvic, urinary, bowel, and sexual symptoms [1]. The exact stage of POP is diagnosed on pelvic exam. A medical history is also important to elicit associated symptoms, since treatment of urinary or fecal symptoms is typically coordinated with treatment for POP. Asymptomatic POP may not require treatment.

The diagnostic evaluation of women with POP is reviewed here.

An overview of the female pelvic exam, POP, and treatment options are discussed separately and include:

(See "The gynecologic history and pelvic examination".)

(See "Pelvic organ prolapse in women: Epidemiology, risk factors, clinical manifestations, and management".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Jun 21, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2013; :CD004014.
  2. Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996; 175:10.
  3. Brubaker L, Norton P. Current clinical nomenclature for description of pelvic organ prolapse. J Pelvic Surg 1996; 2:257.
  4. Committee on Practice Bulletins—Gynecology and the American Urogynecologic Society. Practice Bulletin No. 176: Pelvic Organ Prolapse. Obstet Gynecol 2017; 129:e56.
  5. Hall AF, Theofrastous JP, Cundiff GW, et al. Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am J Obstet Gynecol 1996; 175:1467.
  6. Muir TW, Stepp KJ, Barber MD. Adoption of the pelvic organ prolapse quantification system in peer-reviewed literature. Am J Obstet Gynecol 2003; 189:1632.
  7. Treszezamsky AD, Rascoff L, Shahryarinejad A, Vardy MD. Use of pelvic organ prolapse staging systems in published articles of selected specialized journals. Int Urogynecol J 2010; 21:359.
  8. Vierhout ME, Stoutjesdijk J, Spruijt J. A comparison of preoperative and intraoperative evaluation of patients undergoing pelvic reconstructive surgery for pelvic organ prolapse using the Pelvic Organ Prolapse Quantification System. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:46.
  9. Manonai J, Mouritsen L, Palma P, et al. The inter-system association between the simplified pelvic organ prolapse quantification system (S-POP) and the standard pelvic organ prolapse quantification system (POPQ) in describing pelvic organ prolapse. Int Urogynecol J 2011; 22:347.
  10. ACOG Committee on Practice Bulletins--Gynecology. ACOG Practice Bulletin No. 85: Pelvic organ prolapse. Obstet Gynecol 2007; 110:717.
  11. Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 2001; 185:1388.
  12. Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008; 300:1311.
  13. Elkadry EA, Kenton KS, FitzGerald MP, et al. Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 2003; 189:1551.
  14. Hullfish KL, Bovbjerg VE, Steers WD. Patient-centered goals for pelvic floor dysfunction surgery: long-term follow-up. Am J Obstet Gynecol 2004; 191:201.
  15. Mahajan ST, Elkadry EA, Kenton KS, et al. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 2006; 194:722.
  16. Barber MD, Lambers A, Visco AG, Bump RC. Effect of patient position on clinical evaluation of pelvic organ prolapse. Obstet Gynecol 2000; 96:18.
  17. Digesu GA, Athanasiou S, Cardozo L, et al. Validation of the pelvic organ prolapse quantification (POP-Q) system in left lateral position. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:979.
  18. Visco AG, Wei JT, McClure LA, et al. Effects of examination technique modifications on pelvic organ prolapse quantification (POP-Q) results. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:136.
  19. Shull BL. Clinical evaluation of women with pelvic support defects. Clin Obstet Gynecol 1993; 36:939.
  20. Kenton K, Shott S, Brubaker L. Vaginal topography does not correlate well with visceral position in women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 1997; 8:336.
  21. Walters, MD. Description and classification of lower urinary tract dysfunction and pelvic organ prolapse. In: Urogynecology and Reconstructive Pelvic Surgery, 3rd ed, Walters, MD, Karram MM (Eds), Mosby Elsevier, Philadelphia 2007. p.58.
  22. Parekh M, Swift S, Lemos N, et al. Multicenter inter-examiner agreement trial for the validation of simplified POPQ system. Int Urogynecol J 2011; 22:645.
  23. Brubaker L, Barber MD, Nygaard I, et al. Quantification of vaginal support: are continuous summary scores better than POPQ stage? Am J Obstet Gynecol 2010; 203:512.e1.
  24. Lowder JL, Park AJ, Ellison R, et al. The role of apical vaginal support in the appearance of anterior and posterior vaginal prolapse. Obstet Gynecol 2008; 111:152.
  25. Walters, MD. Evaluation of urinary Incontinence and Pelvic Organ Prolapse. In: Urogynecology and Reconstructive Surgery, 3rd, Walters, MD, Karram, MM (Eds), Mosby Elsevier, Phildelphia 2007. p.69.
  26. www.icsoffice.org/ASPNET_membership/membership/documents/documents.aspx. (Accessed on January 16, 2012).
  27. Bo K, Frawley HC, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J 2017; 28:191.
  28. Flynn, MK, Amundsen, CL. Diagnosis of pelvic organ prolapse. In: Multidisiplinary management of female pelvic floor disorders, Chapple, CR, Zimmerman, PE (Eds), Churchill Livingstone, Philadelphia 2006. p. 120.
  29. Gupta S, Sharma JB, Hari S, et al. Study of dynamic magnetic resonance imaging in diagnosis of pelvic organ prolapse. Arch Gynecol Obstet 2012; 286:953.
  30. Broekhuis SR, Fütterer JJ, Barentsz JO, et al. A systematic review of clinical studies on dynamic magnetic resonance imaging of pelvic organ prolapse: the use of reference lines and anatomical landmarks. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:721.
  31. Ellerkmann RM, Cundiff GW, Melick CF, et al. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 2001; 185:1332.
  32. Gutman RE, Ford DE, Quiroz LH, et al. Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol 2008; 199:683.e1.
  33. Swift S, Woodman P, O'Boyle A, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 2005; 192:795.
  34. Mouritsen L, Larsen JP. Symptoms, bother and POPQ in women referred with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:122.
  35. Visco AG, Brubaker L, Nygaard I, et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:607.
  36. American College of Obstetricians and Gynecologists. Urinary incontinence in women. Obstet Gynecol 2005; 105:1533.
  37. Kleeman S, Goldwasser S, Vassallo B, Karram M. Predicting postoperative voiding efficiency after operation for incontinence and prolapse. Am J Obstet Gynecol 2002; 187:49.
  38. Foster RT Sr, Borawski KM, South MM, et al. A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol 2007; 197:627.e1.
  39. Fitzgerald MP, Kulkarni N, Fenner D. Postoperative resolution of urinary retention in patients with advanced pelvic organ prolapse. Am J Obstet Gynecol 2000; 183:1361.